Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Share-based Compensation: 2019-2024

Historic Share-based Compensation for MDxHealth (MDXH) over the last 6 years, with Dec 2024 value amounting to $1.7 million.

  • MDxHealth's Share-based Compensation rose 13.27% to $18.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.4 million, marking a year-over-year increase of 66.71%. This contributed to the annual value of $1.7 million for FY2024, which is 159.40% up from last year.
  • According to the latest figures from FY2024, MDxHealth's Share-based Compensation is $1.7 million, which was up 159.40% from $665,000 recorded in FY2023.
  • Over the past 5 years, MDxHealth's Share-based Compensation peaked at $1.7 million during FY2024, and registered a low of $665,000 during FY2023.
  • For the 3-year period, MDxHealth's Share-based Compensation averaged around $1.1 million, with its median value being $867,000 (2022).
  • Its Share-based Compensation has fluctuated over the past 5 years, first dropped by 29.05% in 2022, then soared by 159.40% in 2024.
  • Over the past 5 years, MDxHealth's Share-based Compensation (MRY) stood at $1.3 million in 2020, then fell by 5.64% to $1.2 million in 2021, then fell by 29.05% to $867,000 in 2022, then dropped by 23.30% to $665,000 in 2023, then skyrocketed by 159.40% to $1.7 million in 2024.
  • Its last three reported values are $1.7 million in FY2024, $665,000 for FY2023, and $867,000 during FY2022.